Form 4 for NVNO enVVeno Medical Corp
Accepted 2024-12-19 00:00:00 ET · period of report 2024-12-19 · accession 0001493152-24-050865 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-19 | 2024-12-19 | NVNO | BERMAN ROBERT ANDREW | CEO, Dir | P - Purchase | $2.55 | +12.0K | 222.2K | +6% | +$30.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-19 | P | A | 12,000 | $2.55 | 222,236 | D | — | — |